Organisation paid for research Program year 2025 Source: CMS Open Payments

University Retina

Neither a doctor nor a teaching hospital

Research payments

$4,986,967

138 payments

Through program year 2025, University Retina is reported as receiving $4,986,967 in research payments, across 138 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$122,179	9
2021	Research	$1,687,827	54
2020	Research	$1,924,679	55
2019	Research	$1,252,282	20

Breakdown

Who paid Research payments · program years 2019–2025

Genentech, Inc. $4,841,582 126 payments
Sanofi US Services Inc. $122,179 9 payments
Roche TCRC, Inc. $23,206 3 payments

Studies the money was for Research payments · program years 2019–2025

Va2 Phiii Rhine $2,703,570 34 payments
Va2 Phiii $823,843 24 payments
Faricimab Dme Long Term Extension Rhone X $490,449 8 payments
Study of the Port Delivery System With Ranibizumab in Patients With Diabetic MacUlar Edema $457,049 19 payments
Age-related macular degeneration $122,179 9 payments
Port Delivery System for Ranibizumab $118,267 14 payments
Open Label Extension Study to Evaluate the Long Term Safety of Faricimab in Patients With Namd $58,080 3 payments
Ph1 Sad of IL33 in Geographic Atrophy $55,292 3 payments
Phase 2 of Ro7171009 in Ga $43,546 8 payments
Biomarker Ang 2 Inhibitor Study $33,551 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.